Chris is an Executive Director in Perella Weinberg Partners’ advisory business and has been with the firm since 2012. Chris has extensive experience in consumer segments with rapidly evolving regulatory environments and ESG considerations, including reduced harm nicotine, tobacco, cannabis, brewing and spirits.

Representative transactions include advising: Altria on several assignments, including its acquisition of a majority stake in on!, investment of a minority stake in JUUL, acquisition of Nat Sherman, and sale of its 27% stake in SABMiller to ABI; Castle Brands on its sale to Pernod Ricard; Heaven Hill on its acquisition of Deep Eddy Vodka; and Pabst Brewing Company on its sale to Eugene Kasper and TSG Consumer.

Chris has advised on several cannabis transactions in the U.S. and Canada, including Parallel on its merger with Ceres Acquisition Corp. (+ simultaneous $225 million PIPE capital raise), Altria on its investment in Cronos, Cronos on its acquisition of Lord Jones and the first lien creditors of Pyxus International during its Chapter 11 bankruptcy.

Chris has also advised other retail and consumer companies on a variety of M&A, shareholder activism and capital structure assignments. Representative transactions include advising: Kate Spade on its sale to Coach; GameStop on its strategic review, sale of Spring Mobile to Prime Communications, cooperation agreement with activists Hestia Capital and Permit Capital, and exchange offer of outstanding senior notes; Express on its takeover defense from Sycamore Partners; Coldwater Creek on its restructuring and sale of intellectual property to Sycamore Partners; and Henkel on its acquisition of Sun Products.

Chris received a Bachelor of Arts from University of Michigan in Behavioral Economics.